2007 BMW 3 Series 2.0L Petrol · CK57 LPN

The vehicle is currently roadworthy, with a recent PASS on 18 November 2025 at 104,484 miles. The maintenance trend shows stability in critical areas, though the rear sub-frame corrosion has persisted across four consecutive MOTs without significant structural degradation. This indicates that while the issue remains present, it has not progressed to a point of serious compromise as defined by DVSA standards. There were no major safety-critical failures in the last two tests, and the most recent test did not flag any advisories beyond the ongoing sub-frame condition. The mileage accumulation over the past three years has been consistent, averaging approximately 1,230–1,300 miles per year—well below the 5,500-mile average suggested by the total life mileage. This low annual usage aligns with the vehicle’s age and suggests either light use or extended periods of inactivity. Notably, the gap between the 2023 failed test (102,272 miles) and the subsequent pass (102,291 miles) was only 19 miles, indicating a very short interval between retests. This raises questions about whether the repair work was completed promptly or if the second test was conducted under unusual circumstances, but the absence of repeat issues in later tests supports that the exhaust fault was addressed effectively. A buyer should conduct a thorough inspection of the rear sub-frame, particularly around the mounting points and welds, as corrosion has been consistently reported since 2022. The suspension components—especially the front lower arm bushes and steering rack joints—have shown wear multiple times, suggesting potential for increased play or uneven tyre wear if not recently replaced. The rear brake hoses exhibit persistent minor corrosion, which could lead to leaks under pressure; these should be checked for integrity and replaced if necessary. Additionally, the windscreen damage noted in 2022 may have been repaired, but its presence warrants verification to ensure no residual structural weakness or visibility impairment remains.